Therapeutic indications: Pyknoleptic absences as well as complex and atypical absences. Myoclonic-astatic petit mal and myoclonic fits of adolescents (impulsive petit mal), if other medicinal products are not effective and/or are not tolerated.
Click here for complete product code information.
ADVERSE EVENTS SHOULD BE REPORTED
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Neuraxpharm UK Ltd by:
- Email: firstname.lastname@example.org
- Phone number: +44 330 128 0919